title: Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus.
abstract: Cotton rats were immunized via intranasal, intradermal, or enteric routes with respiratory syncytial virus (RSV) or a live recombinant vaccinia virus expressing the RSV F glycoprotein (vaccinia F). The animals were tested for the appearance of RSV-specific antibody responses in the serum, bronchoalveolar lavage, and nasal wash after immunization and for virus replication 4 days after intranasal challenge with RSV. RSV antibody response in the serum and respiratory tract was demonstrated in all immunization groups and was significantly increased after intranasal challenge with RSV. Immunoglobulin A (IgA) antibody response in bronchoalveolar lavage fluid after intranasal or enteric immunization was two- to threefold higher than that after intradermal immunization. Nasal-wash IgA antibody response was not significantly different among three immunization groups, although mean antibody titer was the highest in intranasal immunization group. Complete resistance to replication of RSV challenge was observed in the lungs of cotton rats immunized by the intranasal or enteric routes, whereas a low level of replication was detected in the lungs of rats immunized intradermally. Enteric or intradermal immunization conferred partial protection to the upper respiratory tract, but complete protection of the upper respiratory tract was observed in the intranasal immunization group. These observations suggest that while enteric immunization is quite effective in inducing antibody responses in the respiratory tract, the magnitude of antiviral immunity induced in the respiratory tract after intranasal immunization may be superior to that observed after enteric immunization.
authors.affiliation: Division of Infectious Diseases, Children's Hospital, Buffalo, New York.
authors.forename: T
authors.initials: T
authors.lastname: Kanesaki
authors.forename: B R
authors.initials: BR
authors.lastname: Murphy
authors.forename: P L
authors.initials: PL
authors.lastname: Collins
authors.forename: P L
authors.initials: PL
authors.lastname: Ogra
mesh_terms: D000818:Animals; D000917:Antibody Formation; D002460:Cell Line; D005260:Female; D006801:Humans; D007114:Immunization; D007071:Immunoglobulin A, Secretory / Q000096:biosynthesis*; D007074:Immunoglobulin G / Q000032:analysis; D007700:Kinetics; D008297:Male; D012136:Respiratory Syncytial Viruses / Q000276:immunology*; D010253:Respirovirus Infections / Q000276:immunology*; D016205:Sigmodontinae
chemical_list: D007071:Immunoglobulin A, Secretory; D007074:Immunoglobulin G